In Brazil, the regular updates for Class I medical device registration with ANVISA are essential for maintaining compliance with regulatory requirements. Once a device is registered with ANVISA, the manufacturer must ensure that the device remains compliant with ongoing regulations, including updates to registration, quality standards, labeling, and post-market surveillance.